Upadacitinib for ulcerative colitis and pyoderma gangrenosum in a patient with schizophrenia on long-term risperidone: A case report

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 31, Issue 20

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

470

Figures (1-4)

123

Tables (1-1)

124

Sum=740

Publishing Process of This Article

Item

Count

Browse

Download

Sum=82

May 28, 2025 (publication date) through Jun 18, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Gastroenterol. May 28, 2025; 31(20): 104038
Published online May 28, 2025. doi: 10.3748/wjg.v31.i20.104038

Full Size Figure Download Figure

Figure 2 Skin damage and therapeutic effects.

Citation: He SD, Tian Y. Upadacitinib for ulcerative colitis and pyoderma gangrenosum in a patient with schizophrenia on long-term risperidone: A case report. World J Gastroenterol 2025; 31(20): 104038
URL: https://www.wjgnet.com/1007-9327/full/v31/i20/104038.htm
DOI: https://dx.doi.org/10.3748/wjg.v31.i20.104038